Commentary

In the world of biotech, the assumption is that the two poles of greatest and best activity center around San Francisco on the West Coast and Boston on the East Coast. This assumption is based on the historic role each city has played over...

Venture capitalists are generally not thought of with great affection by most entrepreneurs, which should be no surprise given that venture capitalists turn entrepreneurs away far more often than they let open their checkbooks for them, and have at best ambiguous relationships with most of...

If you are still talking about less than gigabit speeds to end users for any networks that have yet to be implemented, you are way behind the times. After attending 4G WORLD in Chicago this week and listening to those in strategic positions talking about WiMAX...

A jury finds in favor of restaurant employees disciplined for content on social networking site. Long gone are the days when the beauty shop and golf course were the only locations employees could complain about their employers. Now, employees have numerous outlets for venting their...

After hunkering down for some time and receiving some initial responses from the flurry of grant applications that were submitted in the Spring of this year, many Midwest early stage technology companies are once again beginning to consider the private capital markets for funding. In...

In the early days of the modern venture capital industry, way back in the 1950s, most venture capital funds were generalists. That is, while the specific experiences and skills of the managing partners no doubt influenced the kinds of deals that interested various funds,...

Even the best seeds can take a while to germinate. A case in point is the proposal to open seven “emerging technology centers” on University of Wisconsin System campuses to better serve industry while engaging faculty and student research talent. The UW Board of Regents...

A recent article in Biofuels Digest reports that in a presumably recent year the University of California system recorded royalties of $52.5 million on university research spending of almost $3 billion. The number asks whether the public is getting a fair return on its...

In recent years, the top tier Japanese pharma companies, in order to compete against international incursion in its own $78.6 billion home market (or about 10% of the global pharma market), has been forced to globalize. Add to this that the Japanese market growth has...